Cure8 research brief
This study identifies reproducible molecular patterns in UC tissue that could help researchers target non-immune pathways (metabolic/mitochondrial) in addition to inflammation, and it highlights that apparently uninflamed mucosa can carry persistent abnormalities.
Researchers studying UC pathogenesis, biomarker discovery, and drug targets; clinicians interested in molecular differences between UC and Crohn’s disease; patients curious about research into underlying tissue changes in UC.
The study pooled 17 microarray cohorts (1,095 biopsies) and validated findings in nine RNA‑seq cohorts, focusing on comparisons of inflamed UC, uninflamed UC, and inflamed Crohn’s disease versus controls.
The main replicated findings were an upregulated inflammatory transcriptomic profile in inflamed UC and a downregulated metabolic/mitochondrial program driven by PPARGC1A/PPARGC1B/ESRRA that was stronger in UC than CD.
The authors also report that uninflamed UC mucosa differs from control mucosa with suppressed glucuronidation and low-grade interferon and complement signaling, but those constitutive signals were less stable across cohorts and only partly replicated on RNA‑seq.
Overall, the paper proposes a two-layer model: an inflammation-dependent layer superimposed on a mucosa with some persistent molecular abnormalities even when inflammation is not visible.
This is a meta-analysis of public transcriptomic datasets with RNA‑seq validation; the findings are descriptive molecular patterns (gene-expression signals) and do not report clinical trial results or therapeutic effects. Some signals (especially in uninflamed mucosa) were less consistent across cohorts.
Review the original publication for the complete reporting, methods, and context.
Funding disclosed by the source: Politechnika Poznańska
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
This study links an HLA gene (DRB1) to shared T cell receptor patterns in both Crohn’s disease and ulcerative colitis, suggesting common immune targets across IBD subtypes. That could help researchers identify antigens...
Links between IBD genetic risk and specific adult tissue lesion contexts help researchers understand which cell types and tissue programs may mediate inherited susceptibility. That can guide future biomarker and...
The work searches for shared blood-based gene signatures and biomarkers across HLA-B27–linked diseases (including Crohn’s disease and ulcerative colitis), which could point to common mechanisms or cross-disease...
